Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for leukaemia significantly...
Vous n'êtes pas connecté
A discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused by defective stem cells, which produce all the body's different blood cells.
Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for leukaemia significantly...
NeuroScientific Biopharmaceuticals has ventured into stem cell therapy with a $5.1M purchase of unlisted Perth-based company Isopogen, whose tech...
NeuroScientific Biopharmaceuticals has ventured into stem cell therapy with a $5.1M purchase of unlisted Perth-based company Isopogen, whose tech...
European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation in the European Union (EU) for Zemcelpro...
A new way to grow stem cells may help them release more of the signaling proteins they use to repair tissue, potentially improving future treatments.
An international team of scientists just delivered a major breakthrough in diabetes research by successfully 3D printing functional human islets using...
An international team of scientists just delivered a major breakthrough in diabetes research by successfully 3D printing functional human islets using...
A new blood test tracking genetic changes in stem cells may predict leukemia risk and age-related diseases-potentially replacing bone marrow...
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...